key: cord-0714273-ifxju9j0
authors: Zhang, Haijun; Rostamim, Mahboubeh R.; Leopold, Philip L.; Mezey, Jason G.; O’Beirne, Sarah L.; Strulovici-Barel, Yael; Crystal, Ronald G.
title: Reply to Sharma and Zeki: Does Vaping Increase Susceptibility to COVID-19?
date: 2020-10-01
journal: Am J Respir Crit Care Med
DOI: 10.1164/rccm.202006-2351le
sha: 71dda0e2d35e8543953834bda4874e1a6a455400
doc_id: 714273
cord_uid: ifxju9j0

nan

We agree with Sharma and Zeki that the increased expression of ACE2 and TMPRSS2 in the small airway epithelium (SAE) in men and cigarette smokers may play a role in the increased susceptibility to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and that our findings are consistent with those of others (1) (2) (3) (4) (5) (6) (7) . In response to their suggestion that exposure to electronic cigarettes (e-cigs) with or without nicotine may influence ACE2 expression in the airways, we evaluated our prior study assessing the SAE gene expression responses of healthy never-smokers after acute exposure to e-cigs (8) . Ten nonsmokers matched for age, sex, and ethnicity with no history of exposure to tobacco products or e-cigs, were assessed at baseline; this included medical examination, routine blood studies, urine analysis, respiratory questionnaires, chest X-ray, and full lung function, followed by bronchoscopy to obtain SAE by brushing. All subjects were documented to be never-smokers on the basis of their self-reported smoking history and by the absence of urine tobacco metabolites. One week later, all subjects inhaled 10 puffs of a "Blu" brand e-cig (first exposure) and 30 minutes later inhaled 10 more puffs (second exposure). Subjects were randomized to inhale e-cigs with (n = 7) or without (n = 3) nicotine. Two hours after the second e-cig exposure, all subjects were reassessed as at baseline, including bronchoscopy to obtain SAE. SAE cell differentials were similar in both exposure groups at both time points and before and after exposure within the same exposure group. Total RNA was extracted, processed, and hybridized on Illumina HiSeq 2500 (Illumina) (8) . Genomewide fragments per kilobase per million expression values are publicly available in the National Center for Biotechnology Information Gene Expression Omnibus (accession number GSE85121).

The SAE transcriptome at baseline was compared with the SAE transcriptome after e-cig exposure within each group using a paired t test using Partek Genomics Suite Software version 6.6 (Partek). A genome-wide analysis of n = 16,044 genes identified 71 genes significantly modified in the SAE after exposure to e-cigs with nicotine and 65 genes significantly modified in the SAE after exposure to e-cigs without nicotine (8) . Neither ACE2 nor TMPRSS2 were among the significant genes in either comparison. Gene expression analysis of only ACE2 and TMPRSS2 before and after exposure demonstrated no effect on either ACE2 or TMPRSS2 of e-cigs with or without nicotine (Table 1) . Thus, at least for this brand of e-cigs, acute exposure does not affect ACE2 or TMPRSS2 expression, in contrast to cigarette smoke exposure (1) . However, only one e-cig brand was evaluated, and e-cig smoke likely varies among brands and added flavorings (9-13). Thus, although our data related to acute e-cig exposure do not show an effect on ACE2 or TMPRSS2 expression, we agree with Sharma and Zeki that further studies of use of e-cigs are warranted because chronic use and different formulations could have an effect on SARS-CoV-2 expression. n Author disclosures are available with the text of this letter at www.atsjournals.org. Definition of abbreviations: E-cig = e-cigarette; FPKM = fragments per kilobase per million; SAE = small airway epithelium. *SAE was assessed in never-smokers (n = 10) before and after acute exposure (2 3 10 puffs, 30 min apart) to "Blu" brand e-cigarettes. † A random sample (n = 7) of the nonsmokers was exposed to e-cigarettes with nicotine. ‡ A random sample (n = 3) of the nonsmokers was exposed to e-cigarettes without nicotine.

x The expression of each of the genes was compared before exposure (baseline) and after exposure (Day 7) within each group of exposure, separately. Extracorporeal CO 2 Removal and the Alveolar Gas Equation

To the Editor:

As the use of venovenous extracorporeal membrane oxygenation and extracorporeal CO 2 removal (ECCO 2 R) increases to support patients with acute respiratory distress syndrome, an understanding of the physiology of gas exchange and the ramifications for ultraprotective lung ventilation becomes more critical for proper management. In the review "Mechanical Ventilation for Acute Respiratory Distress Syndrome during Extracorporeal Life Support" (1), the authors incorrectly applied a simplified version of the alveolar gas equation (AGE), which led to an unfounded warning that ECCO 2 R could lead to a "marked decrease in Pa O 2 ." The simplified AGE is as follows:

Importantly, the simplified AGE assumes a fixed volume of alveolar gas. However, during ECCO 2 R, the volume of CO 2 entering the alveolus ( _ VCO 2 ) is much less than the amount of oxygen leaving the alveolus ( _ VO 2 ). The difference in these volumes results in passive inflow of fresh gas into the alveolus. Under normal physiologic conditions, this effect is small and can be ignored (hence the common use of the simplified AGE); however, with large changes in the respiratory exchange ratio (RER), the error introduced on calculated Pa O 2 is substantial. To account for the influx of fresh gas, the full AGE, detailed in the appendix of West's Respiratory Physiology primer (2) and skipped by generations of medical students, contains an additional term (highlighted in bold):

The impact of varying amounts of CO 2 removal with ECCO 2 R on Pa O 2 calculated by both the simplified AGE and the full AGE is shown in Figure 1 . The reduction in Pa O 2 is fairly slight when using the full AGE, even with the (unrealistic) assumption of zero oxygen flux across the membrane oxygenator (the effect of which would be to increase RER and further blunt the already small 

Expression of the SARS-CoV-2 ACE2 receptor in the human airway epithelium

Sex difference and smoking predisposition in patients with COVID-19

Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2

Tobacco smoking increases the lung gene expression of ACE2, the receptor of SARS-CoV-2

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Altered lung biology of healthy never smokers following acute inhalation of E-cigarettes

The emerging phenomenon of electronic cigarettes

Evidence, policy, and E-cigarettes: will England reframe the debate?

Chemical hazards present in liquids and vapors of electronic cigarettes

E-cigarettes: an evidence update. A report commissioned by Public Health England

Nicotine without smoke: Tobacco harm reduction

UK: Royal College of Physicians